Authors:
MURRAY AG
SCHECHNER JS
EPPERSON DE
SULTAN P
MCNIFF JM
HUGHES CCW
LORBER MI
ASKENASE PW
POBER JS
Citation: Ag. Murray et al., DERMAL MICROVASCULAR INJURY IN THE HUMAN PERIPHERAL-BLOOD LYMPHOCYTE RECONSTITUTED SEVERE COMBINED IMMUNODEFICIENT (HUPBL-SCID) MOUSE SKIN ALLOGRAFT MODEL IS T-CELL MEDIATED AND INHIBITED BY A COMBINATION OF CYCLOSPORINE AND RAPAMYCIN/, The American journal of pathology, 153(2), 1998, pp. 627-638
Authors:
SULTAN P
SCHECHNER JS
MCNIFF JM
HOCHMAN PS
HUGHES CCW
LORBER MI
ASKENASE PW
POBER JS
Citation: P. Sultan et al., BLOCKADE OF CD2-LFA-3 INTERACTIONS PROTECTS HUMAN SKIN ALLOGRAFTS IN IMMUNODEFICIENT MOUSE HUMAN CHIMERAS/, Nature biotechnology, 15(8), 1997, pp. 759-762
Authors:
CHAMBERS SK
CHAMBERS JT
DAVIS CA
KOHORN EI
SCHWARTZ PE
LORBER MI
HANDSCHUMACHER RE
PIZZORNO G
Citation: Sk. Chambers et al., PHARMACOKINETIC AND PHASE-I TRIAL OF INTRAPERITONEAL CARBOPLATIN AND CYCLOSPORINE IN REFRACTORY OVARIAN-CANCER PATIENTS, Journal of clinical oncology, 15(5), 1997, pp. 1945-1952
Authors:
LEE LS
AUERSVALD LA
CLAUS EB
BIA MJ
FRIEDMAN AL
LORBER MI
BASADONNA GP
Citation: Ls. Lee et al., BODY-SIZE MISMATCH BETWEEN DONOR AND RECIPIENT AND THE DEVELOPMENT OFCHRONIC REJECTION IN RENAL-TRANSPLANTATION, Transplantation proceedings, 29(1-2), 1997, pp. 111-111
Authors:
BASADONNA GP
AUERSVALD LA
OLIVEIRA SC
FRIEDMAN AL
LORBER MI
Citation: Gp. Basadonna et al., PANCREAS AFTER KIDNEY-TRANSPLANTATION - HLA MISMATCH DOES NOT PRECLUDE SUCCESS, Transplantation proceedings, 29(1-2), 1997, pp. 667-667
Citation: Mi. Lorber et al., IN-VIVO DEPLETION OF HOST CD4(-MARROW STEM-CELLS AND TOLERANCE INDUCTION WITH MINIMAL CONDITIONING - DISCUSSION() AND CD8(+) CELLS PERMITS ENGRAFTMENT OF BONE), Surgery, 122(2), 1997, pp. 227-227
Authors:
SULTAN P
MURRAY AG
MCNIFF JM
LORBER MI
ASKENASE PW
BOTHWELL ALM
POBER JS
Citation: P. Sultan et al., PIG BUT NOT HUMAN INTERFERON-GAMMA INITIATES HUMAN CELL-MEDIATED REJECTION OF PIG-TISSUE IN-VIVO, Proceedings of the National Academy of Sciences of the United Statesof America, 94(16), 1997, pp. 8767-8772
Citation: Rh. Kerman et al., CLINICAL RELEVANCE OF ANTI-HLA ANTIBODIES PRE AND POST TRANSPLANT, The American journal of the medical sciences, 313(5), 1997, pp. 275-278
Citation: Mi. Lorber et al., PATHOPHYSIOLOGY AND TREATMENT OF GALLSTONE DISEASE IN ORGAN TRANSPLANT RECIPIENTS, JN. Journal of nephrology, 9(5), 1996, pp. 225-231
Authors:
CHAMBERS SK
DAVIS CA
CHAMBERS JT
SCHWARTZ PE
LORBER MI
HANDSCHUMACHER RE
Citation: Sk. Chambers et al., PHASE-I TRIAL OF INTRAVENOUS CARBOPLATIN AND CYCLOSPORINE-A IN REFRACTORY GYNECOLOGIC CANCER-PATIENTS, Clinical cancer research, 2(10), 1996, pp. 1699-1704
Authors:
SAITO N
SMITH SD
WHEELER MA
SESSA WC
LORBER MI
WEISS RM
Citation: N. Saito et al., HUMAN RENAL-TRANSPLANT REJECTION STIMULATES NITRIC-OXIDE SYNTHASE ACTIVITY AND IL-2 PRODUCTION, The FASEB journal, 10(3), 1996, pp. 4051-4051
Authors:
SMITH SD
WHEELER MA
ZHANG R
WEISS ED
LORBER MI
SESSA WC
WEISS RM
Citation: Sd. Smith et al., NITRIC-OXIDE SYNTHASE INDUCTION WITH RENAL-TRANSPLANT REJECTION OR INFECTION, Kidney international, 50(6), 1996, pp. 2088-2093
Authors:
SULTAN P
SCHECHNER JS
JENNIFER MF
HOCHMAN PS
LORBER MI
ASKENASE PW
POBER JS
Citation: P. Sultan et al., BLOCKADE OF CD2-LFA-3 INTERACTIONS PROTECTS HUMAN SKIN ALLOGRAFTS IN HUPBL-SCID MOUSE, Circulation, 94(8), 1996, pp. 301-301
Authors:
MORRISSEY PE
LORBER KM
MARCARELLI M
BIA MJ
KLIGER AS
LORBER MI
Citation: Pe. Morrissey et al., IMMUNOLOGICAL MONITORING AFTER ORGAN-TRANSPLANTATION - RELATIONSHIP BETWEEN EPSTEIN-BARR-VIRUS INFECTION AND CD19(-CELLS MEASURED BY FLOW-CYTOMETRY() B), Transplantation proceedings, 27(1), 1995, pp. 1428-1430
Authors:
MORRISSEY PE
LORBER KM
MARCARELLI M
BIA MJ
KLIGER AS
LORBER MI
Citation: Pe. Morrissey et al., POSTTRANSPLANT EPSTEIN-BARR-VIRUS INFECTION IS ASSOCIATED WITH ELEVATED LEVELS OF CD19(-LYMPHOCYTES() B), Transplantation, 59(4), 1995, pp. 637-640
Authors:
HIBBERD PL
TOLKOFFRUBIN NE
CONTI D
STUART F
THISTLETHWAITE JR
NEYLAN JF
SNYDMAN DR
FREEMAN R
LORBER MI
RUBIN RH
Citation: Pl. Hibberd et al., PREEMPTIVE GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS ANTIBODY-POSITIVE RENAL-TRANSPLANT RECIPIENTS - A RANDOMIZED CONTROLLED TRIAL, Annals of internal medicine, 123(1), 1995, pp. 18-26
Authors:
POWELSON JA
COSIMI AB
LEWIS WD
ROHRER RJ
FREEMAN RB
VACANTI JP
JONAS M
LORBER MI
MARKS WH
BRADLEY J
JENKINS RL",MAKOWA,KATZ,STARZL
Citation: Ja. Powelson et al., HEPATIC RETRANSPLANTATION IN NEW-ENGLAND - A REGIONAL EXPERIENCE AND SURVIVAL MODEL, Transplantation, 55(4), 1993, pp. 802-806